Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
Amy S PallerAshish BansalEric L SimpsonMark BoguniewiczAndrew BlauveltElaine C SiegfriedEmma Guttman-YasskyThomas HultschZhen ChenPaola Mina-OsorioYufang LuAna Beatris RossiXinyi HeMohamed KamalNeil M H GrahamGianluca PirozziMarcella RuddyLaurent EckertAbhijit GadkariPublished in: American journal of clinical dermatology (2020)
ClinicalTrials.gov; NCT03054428. Adolescents with atopic dermatitis: does dupilumab improve their signs, symptoms, and quality of life? (MP4 212916 kb).